Global launch of X-ZELL Cryoimmunostaining™ Suite confirmed

X-ZELL Cryoimmunostaining™ Suite to feature at Medlab Asia 2019 Singapore, February 2019 – Singaporean medical technology start-up X-ZELL will preview the production version of the world’s first slide-based, eight-channel immunostaining solution at the 2019...

X-ZELL signs research collaboration agreement with DxD Hub

X-ZELL signs research collaboration agreement with Diagnostics Development Hub X-ZELL is now officially partnering with Singapore’s DxD Hub.   Singapore, December 2018 – In a move that will accelerate the company’s capabilities and scale up its...

X-ZELL CEO presenting breakthrough research at EMUC18

X-ZELL CEO presenting breakthrough CEC research at EMUC18 Amsterdam, November 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has used the 2018 European Multidisciplinary Congress on Urological Cancers (EMUC18) in Amsterdam as a platform to present new insights into the...

X-ZELL taking centre stage at inaugural A*CCELERATE NOW expo

X-ZELL taking centre stage at inaugural A*CCELERATE NOW expo Singapore, November 2018 – X-ZELL  has been one of eight promising biotechnology start-ups selected to exhibit at the inaugural A*CCELERATE NOW exhibition in Singapore. The landmark event – held in a move to...